Brookshire Cypress Jersey Village Katy
1.9K Reviews    |    4.7 Star Rating    |    20+ years of experience    |    75k+ Patients Treated
Call

Hepatomegaly Sensation / Fullness in RUQ Patient Journey in Cypress, TX

How do clinicians confirm whether the liver is enlarged, distinguish diffuse enlargement from cysts or a focal mass, identify metabolic, viral, cardiac, infiltrative, or malignant causes, and separate liver disease from gallbladder or other right-upper-abdominal mimics?

Ethan’s path from RUQ tenderness, fatigue, nausea, dark urine, pale stool, and new jaundice after a viral prodrome to acute hepatitis B with hepatomegaly, targeted care, and documented follow-up

Medically reviewed by: Dr. Bharat Pothuri, MD, FACG Specialty: Gastroenterology & Hepatology Last updated: 2026-08-17

GastroDoxs GutGuardians™

Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.

Ethan’s Story: Acute hepatitis B presenting with tender hepatomegaly and jaundice

A 34-year-old biomedical equipment technician looking for an explanation for RUQ tenderness, fatigue, nausea, dark urine, pale stool, and new jaundice after a viral prodrome

Ethan was a biomedical equipment technician whose first explanation was a prolonged stomach virus.

The decision changed when urine darkened and the eyes turned yellow. The combination of RUQ tenderness, fatigue, nausea, dark urine, pale stool, and new jaundice after a viral prodrome required a more specific evaluation.

Marked hepatocellular enzyme elevation, bilirubin, HBsAg, and IgM anti-HBc supported acute hepatitis B. Ultrasound confirmed mild hepatomegaly and excluded biliary obstruction, while INR and mental status assessed liver-failure risk.

The final plan used supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed. Follow-up measured safety, symptom resolution, objective recovery, and the risk of recurrence.

The jaundice and blood-test pattern made this an acute hepatitis pathway, not a symptom to watch casually.

The First Signs: How Ethan’s Symptoms Began

Ethan first noticed RUQ tenderness and assumed a prolonged stomach virus.

Additional symptoms developed: RUQ tenderness, fatigue, nausea, dark urine, pale stool, and new jaundice after a viral prodrome.

The pattern became harder to dismiss when urine darkened and the eyes turned yellow.

That change led to testing selected for acute hepatitis B with hepatomegaly rather than another round of symptom-only treatment.

When Ethan Understood What Had Changed

The turning point was replacing the assumption of a prolonged stomach virus with evidence supporting acute hepatitis B with hepatomegaly.

At first, Ethan tried to fit the symptoms into a familiar explanation.

The pattern no longer fit when urine darkened and the eyes turned yellow.

Marked hepatocellular enzyme elevation, bilirubin, HBsAg, and IgM anti-HBc supported acute hepatitis B. Ultrasound confirmed mild hepatomegaly and excluded biliary obstruction, while INR and mental status assessed liver-failure risk.

The team explained why supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed addressed the supported mechanism and what findings would require escalation.

That explanation turned several disconnected tests and recommendations into one coherent care path.

Uncertainty Became a Defined Question

Testing focused on confirming or excluding acute hepatitis B with hepatomegaly.

Urgency Was Matched to Risk

The care setting reflected bleeding, obstruction, infection, ischemia, perforation, and clinical stability.

Follow-Up Had an Endpoint

Symptoms, laboratory recovery, imaging, endoscopy, pathology, or postoperative milestones were used as appropriate.

Why Ethan Needed More Than Symptom-Only Treatment

The record required one interpretation that connected the symptom pattern, diagnostic evidence, immediate risks, treatment mechanism, and follow-up endpoint.

The Initial Explanation Was Incomplete

The assumption of a prolonged stomach virus no longer accounted for the full pattern.

Objective Evidence Changed the Differential

The team considered MASLD or MASH, alcohol-related disease, viral and autoimmune hepatitis, congestive hepatopathy, biliary obstruction, cystic and infiltrative disease, benign and malignant masses, gallbladder disease, gastric or colonic fullness, lung disease, and abdominal-wall pain.

Treatment Needed a Supported Target

The plan focused on acute hepatitis B with hepatomegaly rather than the symptom label alone.

Recovery Needed Measurement

The team defined symptom, laboratory, imaging, endoscopic, pathology, or postoperative endpoints appropriate to the case.

A Symptom Pattern Needs a Cause, a Safety Assessment, and a Follow-Up Endpoint

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care.

How Ethan’s Symptoms Led to Cause-Directed Care

The sequence moved from a nonspecific complaint to risk assessment, targeted testing, a supported diagnosis, treatment matched to the mechanism, and documented follow-up.

Testing Defines the Problem

Marked hepatocellular enzyme elevation, bilirubin, HBsAg, and IgM anti-HBc supported acute hepatitis B. Ultrasound confirmed mild hepatomegaly and excluded biliary obstruction, while INR and mental status assessed liver-failure risk.

Review Hepatomegaly Sensation / Fullness in RUQ →

The Mechanism Directs Treatment

The supported pattern was acute hepatitis B with hepatomegaly, so the plan used supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed.

Review the treatment guide →

Follow-Up Measures Recovery

Ethan’s jaundice and tenderness resolved, liver tests normalized, and follow-up confirmed viral clearance without chronic infection.

Schedule An Evaluation →

Decisions That Shaped Ethan’s Evaluation

The first decisions are whether the fullness reflects true liver enlargement, whether jaundice or fever indicates inflammation or obstruction, whether heart failure is causing venous congestion, whether a focal mass needs liver-protocol imaging, and whether symptoms actually arise from the gallbladder or another organ.

Confirm the Anatomy

Examination and ultrasound determine liver size, surface, texture, focal lesions, bile ducts, gallbladder, spleen, vessels, and fluid.

Define the Laboratory Pattern

AST, ALT, alkaline phosphatase, bilirubin, albumin, INR, CBC, platelets, and renal tests distinguish injury, cholestasis, function, and portal effects.

Match Causes to Risk

Metabolic factors, alcohol, medicines, viral exposure, autoimmunity, heart disease, cancer history, and family cystic disease direct testing.

Characterize Focal Findings

Liver-protocol CT or MRI evaluates a mass or complex cyst rather than relying on a nonspecific ultrasound label.

Measure Fibrosis and Complications

FIB-4, elastography, portal findings, surveillance eligibility, and selected biopsy answer questions that change prognosis or treatment.

Severe or rapidly worsening RUQ pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major abdominal or leg swelling, or rapidly worsening weakness requires urgent assessment.

How Clinicians Interpreted Ethan’s Acute Hepatitis B With Liver Enlargement

RUQ fullness is interpreted by connecting physical findings, liver size and texture, focal versus diffuse imaging, hepatocellular versus cholestatic laboratory patterns, synthetic function, portal hypertension, cardiac congestion, metabolic and viral risks, and nonhepatic alternatives.

Hepatomegaly Is a Finding

An enlarged liver is not a final diagnosis; the distribution, tissue pattern, laboratory results, and clinical setting identify the mechanism.

Steatosis Does Not Stage Fibrosis

Routine imaging can show liver fat but cannot reliably distinguish simple steatosis from steatohepatitis or define fibrosis severity.

Congestion Can Enlarge the Liver

Right-sided heart pressure can produce a tender enlarged liver, pulsatility, edema, ascites, and abnormal liver tests.

A Mass Requires Dedicated Characterization

Risk factors, multiphase enhancement, AFP in context, prior imaging, and multidisciplinary review guide HCC or metastatic evaluation.

Acute Hepatitis B With Liver Enlargement

Marked hepatocellular enzyme elevation, bilirubin, HBsAg, and IgM anti-HBc supported acute hepatitis B. Ultrasound confirmed mild hepatomegaly and excluded biliary obstruction, while INR and mental status assessed liver-failure risk.

What Happened During Ethan’s Stable GI Review

A stable visit maps fullness duration, pain, meal and movement relation, jaundice, stool and urine color, weight, fever, swelling, breathlessness, alcohol, medicines, metabolic and viral risk, heart disease, family history, laboratory trends, and all prior liver and gallbladder images.

Symptom and Examination Map

Define fullness versus pain, tenderness, palpable edge, abdominal wall features, ascites, spleen, edema, and cardiopulmonary signs.

Liver Laboratory Review

Compare injury, cholestasis, bilirubin, albumin, INR, platelets, renal function, and trends rather than labeling one enzyme result.

Ultrasound and Image Reconciliation

Confirm measurements, steatosis, cysts, masses, ducts, vessels, gallbladder, spleen, and fluid on the original report and images when available.

Cause-Specific Testing

Select viral, autoimmune, iron, cardiac, metabolic, genetic, or oncologic studies from the actual risk pattern.

A Measurable Endpoint

Track symptoms, liver tests, size or lesion imaging, fibrosis risk, cardiac volume status, nutrition, and surveillance needs.

From Acute Hepatitis B With Liver Enlargement to a Defined Care Plan

Treatment targets the cause of enlargement or the true source of fullness. Plans may address metabolic liver disease, alcohol, viral hepatitis, heart failure, biliary disease, symptomatic cyst burden, a focal tumor, or a nonhepatic mimic while monitoring liver function and fibrosis.

Treat Metabolic Liver Risk

Use sustainable weight, nutrition, activity, diabetes, lipid, and blood-pressure management with fibrosis-based follow-up.

Remove Hepatic Injury

Coordinate alcohol cessation, antiviral therapy, autoimmune treatment, or medication changes when supported.

Relieve Venous Congestion

Cardiac therapy and careful volume management address congestive hepatopathy rather than liver-directed treatment alone.

Manage Cysts or Masses Selectively

Observation, interventional treatment, surgery, transplant review, or oncology care depends on symptoms, anatomy, diagnosis, and liver reserve.

Treat the Mimic

Gallbladder, stomach, colon, lung, or abdominal-wall disease receives its own pathway when liver size and testing are normal.

How the Pathway Applied to Ethan

For this composite, the plan used supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed. The result was measured through this outcome: Ethan’s jaundice and tenderness resolved, liver tests normalized, and follow-up confirmed viral clearance without chronic infection.

Why Cypress, TX Patients Benefit From Coordinated Records and Follow-Up

The Cypress, TX plan linked the original acute or diagnostic setting with gastroenterology, radiology, pathology, surgery, primary care, and other services needed for acute hepatitis B with hepatomegaly.

One Diagnostic Record

The Cypress, TX review reconciled imaging, endoscopy, pathology, laboratory trends, and treatment response.

Urgency Remained Explicit

The Cypress, TX office handled stable review; active emergency warning signs returned to hospital-level care.

Specialists Had Defined Questions

Radiology, pathology, surgery, pelvic-floor, vascular, infectious-disease, or IBD input was requested only when it could change the plan.

Follow-Up Used Measurable Endpoints

The Cypress, TX baseline allowed symptoms, blood counts, imaging, mucosal findings, or postoperative milestones to be compared over time.

GastroDoxs RUQ Fullness and Liver Liver And Ruq Symptom Evaluation for Cypress, TX

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care.

Address

Grand Cypress Doctors' Pavilion I, 22215 Cypresswood Drive, Suite 315, Cypress, TX 77433

Office Hours

Monday through Friday, 7:00 AM to 7:00 PM

Areas Served

Cypress, Bridgeland, Towne Lake, Fairfield, Cypresswood, and Cy-Fair

Main Access Routes

Cypresswood Drive, Barker Cypress Road, Fry Road, and Highway 290

Planning RUQ Fullness and Liver Evaluation and Follow-Up

Coverage can differ for liver and blood testing, ultrasound, elastography, CT or MRI, viral and autoimmune studies, echocardiography, liver-protocol imaging, biopsy, cyst intervention, oncology care, and surveillance.

Confirm the Care Setting

Ask whether the planned service belongs in an office, endoscopy center, radiology department, hospital, infusion site, or surgical facility.

Verify Diagnostic Coverage

Imaging, endoscopy, pathology, capsule, functional testing, or specialist review may have separate authorization and cost-sharing rules.

Send Existing Records First

Prior images, pathology, operative notes, and laboratory trends can prevent unnecessary repetition and clarify the correct next service.

Do Not Delay Emergency Care

Coverage questions should never postpone evaluation of severe pain, major bleeding, persistent vomiting, sepsis signs, or bowel obstruction.

Why Ethan Chose the Final Care Strategy

The selected plan matched diagnostic certainty, immediate risk, anatomy, the supported mechanism, prior response, and the least invasive option likely to be safe and effective.

The Pattern Was Supported

Marked hepatocellular enzyme elevation, bilirubin, HBsAg, and IgM anti-HBc supported acute hepatitis B. Ultrasound confirmed mild hepatomegaly and excluded biliary obstruction, while INR and mental status assessed liver-failure risk.

The Risks Were Defined

The team considered MASLD or MASH, alcohol-related disease, viral and autoimmune hepatitis, congestive hepatopathy, biliary obstruction, cystic and infiltrative disease, benign and malignant masses, gallbladder disease, gastric or colonic fullness, lung disease, and abdominal-wall pain.

Treatment Matched the Cause

The plan used supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed.

Escalation Criteria Were Explicit

New or worsening warning signs, failure to improve, objective recurrence, or a new structural concern triggered reassessment.

Diffuse Liver Enlargement, Focal Lesion, Congestion, and RUQ-Mimic Pathways

The pathway depends on diffuse versus focal imaging, liver-test pattern, fibrosis and function, cardiac findings, fever or jaundice, weight change, and evidence that another right-upper-abdominal organ is responsible.

Diffuse Metabolic or Inflammatory Pathway

Stage fibrosis and treat the supported metabolic, alcohol, viral, or immune cause.

Best for: Diffuse enlargement or steatosis with risk factors

Limitations: Size and enzymes do not define fibrosis

Takeaway: Treat cause and stage separately

Congestive Pathway

Coordinate cardiac assessment and volume management.

Best for: Edema, breathlessness, elevated venous pressure, pulsatile or tender liver

Limitations: Aggressive diuresis may affect kidneys

Takeaway: Treat the heart-liver connection

Focal Lesion Pathway

Use liver-protocol CT or MRI and multidisciplinary review.

Best for: Mass, complex cyst, cirrhosis, hepatitis B, or cancer history

Limitations: Biopsy is not automatically the first step

Takeaway: Characterize before intervening

Nonhepatic RUQ Pathway

Evaluate gallbladder, stomach, colon, lung, and abdominal wall.

Best for: Normal liver size with meal, movement, bowel, or respiratory clues

Limitations: Symptoms can overlap

Takeaway: Do not force a liver diagnosis

When Symptoms Associated With Hepatomegaly Sensation / Fullness in RUQ Need Prompt or Emergency Care

These warning signs can indicate acute hepatitis, biliary infection or obstruction, liver decompensation, major bleeding, severe cardiac congestion, tumor complication, sepsis, or another time-sensitive abdominal diagnosis.

Severe, constant, or rapidly worsening right-upper-abdominal pain
Fever, shaking chills, or rapidly worsening weakness
New or rapidly worsening jaundice, dark urine, or pale stool
Confusion, unusual sleepiness, personality change, or inability to stay awake
Vomiting blood, coffee-ground material, black stool, or heavy rectal bleeding
Persistent vomiting or inability to keep fluids down
Shortness of breath, chest pain, fainting, or new major leg swelling
Rapidly increasing abdominal size, tense swelling, or severe tenderness
Unintended weight loss, a new palpable mass, or rapidly increasing fullness
Very low urine output, low blood pressure, or signs of shock

Ethan’s Life After a Cause-Directed Plan

How care for acute hepatitis B with hepatomegaly changed symptoms, safety, and follow-up

Ethan’s jaundice and tenderness resolved, liver tests normalized, and follow-up confirmed viral clearance without chronic infection.

The result followed supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed.

Follow-up did not rely on symptom improvement alone; relevant blood counts, nutrition, inflammatory markers, imaging, endoscopy, pathology, bowel function, or postoperative findings were considered.

Ethan understood which recurrence patterns could use planned review and which warning signs required emergency assessment.

The record preserved the diagnostic reasoning so future clinicians could distinguish a known recurrence from a new and unrelated GI problem.

The jaundice and blood-test pattern made this an acute hepatitis pathway, not a symptom to watch casually.
Educational Disclaimer

This educational composite illustrates acute hepatitis B presenting with tender hepatomegaly and jaundice. It does not represent a specific patient, establish a diagnosis, or promise a result. Severe or rapidly worsening RUQ pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major abdominal or leg swelling, or rapidly worsening weakness requires urgent assessment.

Hepatomegaly Sensation / Fullness in RUQ FAQs in Cypress, TX

Answers about causes, diagnostic testing, treatment choices, complications, follow-up, office access, and urgent warning signs

In Cypress, TX, Ethan’s evaluation supported acute hepatitis B with hepatomegaly. The conclusion used examination, liver and blood tests, ultrasound, targeted CT or MRI, cardiac assessment, and disease-specific testing rather than sensation alone.

No. A Cypress, TX patient may feel fullness from the liver, gallbladder, stomach, colon, abdominal wall, lung, or fluid accumulation. Examination and imaging confirm whether the liver is actually enlarged.

Causes in a Cypress, TX patient include steatotic liver disease, alcohol, viral or autoimmune hepatitis, venous congestion from heart disease, cysts, infiltrative disorders, storage disease, benign masses, and cancer.

The Cypress, TX workup used CBC and metabolic panel, AST and ALT, bilirubin, alkaline phosphatase, albumin and INR, complete hepatitis testing with HBV DNA when indicated, ultrasound, and serial acute-liver-failure assessment. Testing is matched to the suspected cause and whether jaundice, heart failure, infection, a focal mass, fibrosis, or liver-function loss is present.

Yes. Liver enzymes can be normal in steatotic liver disease, cystic disease, congestion, infiltrative conditions, or even advanced chronic disease. A Cypress, TX evaluation interprets laboratory results with imaging and clinical context.

Often. Ultrasound can confirm liver size and assess texture, cysts, bile ducts, gallbladder, vessels, and fluid in a Cypress, TX patient. CT or MRI may be needed for a focal lesion, complex cysts, or vascular questions.

The Cypress, TX plan used supportive care and avoidance of alcohol and hepatotoxic exposure, transmission prevention and contact vaccination counseling, close laboratory monitoring, and antiviral or transplant-center care if severe or protracted disease criteria developed. Treatment targeted the supported metabolic, cardiac, viral, cystic, malignant, or nonhepatic cause rather than trying to reduce liver size without a diagnosis.

It can, but most enlarged livers in Cypress, TX are not caused by cancer. A new focal mass, cirrhosis, hepatitis B, weight loss, rapidly increasing fullness, or abnormal surveillance imaging requires expedited liver-protocol evaluation.

GastroDoxs evaluates stable RUQ fullness and suspected liver enlargement for Cypress, TX patients at Grand Cypress Doctors' Pavilion I, 22215 Cypresswood Drive, Suite 315, Cypress, TX 77433. Office hours are Monday through Friday, 7:00 AM to 7:00 PM.

A Cypress, TX patient should seek urgent care for severe or rapidly worsening pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major swelling, or rapidly worsening weakness.

GastroDoxs GutHero Quest™

  1. 1

    Confirm Liver Size

    Use examination and imaging to distinguish true hepatomegaly from a perceived RUQ sensation.

  2. 2

    Classify the Pattern

    Separate diffuse enlargement, congestion, cystic disease, focal mass, and nonhepatic causes.

  3. 3

    Measure Injury and Function

    Review liver-test pattern, bilirubin, albumin, INR, platelets, kidneys, and portal findings.

  4. 4

    Test the Leading Cause

    Use metabolic, viral, autoimmune, cardiac, genetic, or oncologic testing selectively.

  5. 5

    Treat the Mechanism

    Address liver disease, cardiac congestion, cyst or tumor anatomy, biliary disease, or another RUQ source.

  6. 6

    Track Recovery and Surveillance

    Measure symptoms, laboratory trends, fibrosis, imaging change, function, and screening needs.

Need a RUQ Fullness and Liver Review in Cypress, TX?

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care. Stable review is available in Cypress, TX.